Skip to content

Legal status · United States

Is Thymosin alpha-1 with KPV and LL-37 legal in the United States?

Written by Reviewed Sep 2026

Not approvedImmuneStudies in people cited: 3

Direct answer

No. Thymosin alpha-1 with KPV and LL-37 is not an approved medicine in the United States. Its legal category is "Not approved; research use only". Nothing that contains it is allowed for any use in people. Vials labeled "for research use only" get no exception: that label does not make them legal to use in people. On the evidence, 3 completed human trials are cited on its profile.

People given it
1,140
Found nothing
1

Legal category

Not approved; research use only

The FDA put thymosin alpha-1 on its list of substances too risky for pharmacies to mix. LL-37 and KPV are not approved, and are sold as 'research use only'.

Reviewed Sep 2026. This is a legal category, not legal advice.

A "research use only" label on a vial does not make it legal to use on people.

Thymosin alpha-1 with KPV and LL-37 in the United States at a glance

Legal categoryNot approved; research use only
NoteThe FDA put thymosin alpha-1 on its list of substances too risky for pharmacies to mix. LL-37 and KPV are not approved, and are sold as 'research use only'.
FDA approval statusThymosin alpha-1 is approved in several countries outside the United States, but not by the FDA. LL-37 and KPV are not approved anywhere. The combination has never been reviewed.
Studies in people3 of 5 sources on the profile
ReviewedSep 2026

The legal category and note come from the Thymosin alpha-1 with KPV and LL-37 profile. We checked them against U.S. Food and Drug Administration (FDA) listings on the reviewed date.

What this means

  • 01

    No product containing Thymosin alpha-1 with KPV and LL-37 is approved by FDA for any use in the United States. So nothing on sale is allowed for use in people.

  • 02

    "Research use only" is a label sellers put on. It is not a legal category that allows use in people, and it does not get a product out of medicines law.

  • 03

    Importing it, supplying it or promoting it for use in people can fall under medicines law in the United States. This page is general information, not legal advice.

What Thymosin alpha-1 with KPV and LL-37 is

A three-peptide immune blend from the clinic end of the market. The ingredient with the biggest study, thymosin alpha-1, was tested in 1,106 adults with sepsis, a life-threatening blood infection. It did not lower deaths at 28 days: people on the dummy shot did just as well. LL-37 has two small studies as a wound cream, both with good results. KPV has no data in people. Nobody has tested the mix, and no vial size is standard.

The pitch is that one peptide organises the immune system, one calms swelling, and one kills germs while helping tissue heal. Each third has its own evidence.

How it works: Thymosin alpha-1 tunes the immune system's T cells and the signals they use, such as interleukin-2 and interferon gamma. LL-37 is a germ-killing peptide.

Approval history: Thymosin alpha-1 is approved in several countries outside the United States, but not by the FDA. LL-37 and KPV are not approved anywhere. The combination has never been reviewed.

How FDA treats this kind of product

Approves prescription drugs, each for a named use. It also acts against unapproved products, including peptides sold online. Compounding pharmacies, which mix drugs to order, may make some compounds with a prescription. That only applies when the FDA puts the compound in a category of bulk ingredients it allows.

The legal category above is how The Longevity Archive reads U.S. Food and Drug Administration listings for Thymosin alpha-1 with KPV and LL-37 on the reviewed date. It is not a legal opinion. Rules change. Bringing a compound into the country, prescribing it and owning it can each be treated differently. Check with the agency before you act on anything here.

Check FDA directly

Thymosin alpha-1 with KPV and LL-37 in sport and the military

Whether Thymosin alpha-1 with KPV and LL-37 is banned in sport is set by the World Anti-Doping Code and by military rules, not by its legal status in the United States. Before you compete or get tested, look up Thymosin alpha-1 with KPV and LL-37 by name on the Prohibited List, or look up a named product in Global DRO. Under the World Anti-Doping Code, category S0 bans, at all times, any drug-like substance that meets two tests. No other section of the List covers it. And no government health regulator anywhere has a current approval for it as a treatment in people. Many substances that are approved somewhere are banned by name in another section. So approval does not mean a substance is allowed in sport.

The rules you compete or serve under decide this, not this page.

Thymosin alpha-1 with KPV and LL-37 in other countries

Frequently asked questions

Is Thymosin alpha-1 with KPV and LL-37 legal in the United States?

No. Thymosin alpha-1 with KPV and LL-37 is not an approved medicine in the United States. Its legal category is "Not approved; research use only". Nothing that contains it is allowed for any use in people. Vials labeled "for research use only" get no exception: that label does not make them legal to use in people. On the evidence, 3 completed human trials are cited on its profile. Note: The FDA put thymosin alpha-1 on its list of substances too risky for pharmacies to mix. LL-37 and KPV are not approved, and are sold as 'research use only'.

Can I buy Thymosin alpha-1 with KPV and LL-37 in the United States?

There is no approved product to buy. In the United States, Thymosin alpha-1 with KPV and LL-37 has the legal category "Not approved; research use only". So no licensed pharmacy product exists. Sellers who list it "for research use only" are not selling it for use in people, and that label does not change its legal status. Sellers named on the price pages are ranked by certificate tier, then price, and any affiliate income is disclosed there. Naming a seller is not a recommendation to buy or use anything. Note: The FDA put thymosin alpha-1 on its list of substances too risky for pharmacies to mix. LL-37 and KPV are not approved, and are sold as 'research use only'.

Is Thymosin alpha-1 with KPV and LL-37 FDA approved?

No. FDA status: Thymosin alpha-1 is approved in several countries outside the United States, but not by the FDA. LL-37 and KPV are not approved anywhere. The combination has never been reviewed.. Current US legal category: "Not approved; research use only". On the evidence, 3 completed human trials are cited on its profile.

Related compounds in the United States

Full research profile

How Thymosin alpha-1 with KPV and LL-37 works, the studies we cite, FDA status and the full legal summary are all on its compound profile.

Thymosin alpha-1 with KPV and LL-37 profile

This page is general information about the legal status of Thymosin alpha-1 with KPV and LL-37 in the United States, current as of Sep 2026. It is not legal advice. Legal status changes. For your own situation, check with U.S. Food and Drug Administration or ask a lawyer. Educational use only. This database summarizes published research and is not medical advice. Where a dose appears it is a record of what a trial or clinic ran, or what people describe doing, with its source attached. Nothing here is a recommendation for personal use. Sellers named on the price pages are ranked by certificate tier, then price, and any affiliate income is disclosed there. Naming a seller is not a recommendation to buy or use anything.